To hedge against structural volatility in legacy petrochemicals, Formosa Plastics Corporation (台塑公司; 1301 TW) is accelerating its corporate transformation into advanced electronics and healthcare supply chains. At the company’s general shareholders' meeting on May 28, 2026, Chairman Kuo Wen-pao detailed a NT$29.2 billion capital expenditure program targeting 27 core specialty assets across three high-value sectors: semiconductor chemicals, green energy/environmental solutions, and healthcare materials. The capital deployment is projected to yield an annualized production value of NT$300 billion, driving the company's high-margin premium differentiated product index from 50% up to 60% by the end of 2026.

Advanced Monomers and Advanced Polymers: The specialized technology transfer and co-development programs are anchored in critical lithography and deposition materials. Advanced polymers under construction include 1-hexene, Polyolefin Elastomers (POE) for clean-energy systems, and Polyaryletherketone (PAEK) for advanced biomedical and industrial applications. Formosa Plastics confirmed that its domestic 1-hexene and PAEK manufacturing assets will reach mechanical completion and achieve commercial volume production within this calendar year.

Subsidiary Fab Integration and Capacity Expansions: Formosa Plastics' subsidiaries and cross-industry joint ventures are rapidly embedding themselves into the front-end supply chains of advanced semiconductor fabs:

• Formosa Sumco Technology (台勝高): The newly constructed 12-inch silicon wafer fab located at the Mailiao complex initiated commercial shipments in Q4 2025, ramping up high-purity wafer allocations for advanced sub-nanometer nodes.
• Formosa Daikin (台塑大金): Specializing in ultra-pure electronic-grade hydrofluoric acid (HF), the unit commands a domestic semiconductor market share exceeding 55%. To meet the demand generated by advanced logic fab expansions, construction has commenced on Phase II of its Dafa facility.
• Formosa Tokuyama (台塑德山): This 50-50 joint venture produces electronic-grade Isopropyl Alcohol (IPA) for front-end wafer cleaning. The asset is executing its Phase II production expansion alongside a dedicated high-purity IPA waste-solvent recovery facility.

Global Infrastructure and New Materials Timeline: Formosa Plastics is managing nine active capital expansion and material transformation initiatives across Taiwan, mainland China, and the United States, representing a consolidated investment of NT$24.3 billion, with rolling completions scheduled to begin in H2 2026. Key infrastructure rollouts include the carbon fiber and precursor expansion at the Renwu site, the conversion of LLDPE capacity to specialty granular POE (gPOE) elastomers at Mailiao, and high-purity acetonitrile units. Internationally, the company's chemical logistics terminal in Ningbo, China, is nearing completion, while its Texas 1-hexene plant is on track for formal production startup in August 2026.

Resource:台塑轉型 衝刺半導體領域 同步布局綠能環保、醫療保健